Icecure Medical vs Intelligent BIO Solutions
Intelligent BIO Solutions is the larger business, with $4.2m of revenue in fiscal 2026 against $3.4m for Icecure Medical (1.2 times as much). Intelligent BIO Solutions grew faster (38.1% against 2.7%). Intelligent BIO Solutions kept more of each dollar of sales as profit: a net margin of -294.9% against -445.6%. Intelligent BIO Solutions carries less debt relative to equity (0.0% against 0.1%).
| Latest fiscal year | Icecure MedicalICCM, 2025 | Intelligent BIO SolutionsINBS, 2026 |
|---|---|---|
| Revenue | $3.4m | $4.2m |
| Revenue growth | 2.7% | 38.1% |
| Net income | −$15.1m | −$12.4m |
| Operating margin | -446.7% | -299.1% |
| Net margin | -445.6% | -294.9% |
| Return on equity | -188.8% | — |
| Free cash flow | −$14.6m | −$12.1m |
| Cash | $8.9m | $4.0m |
| Total debt | $13,000 | $0 |
| Debt to equity | 0.1% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $57.0m | $5.1m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |